Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous syntocinon versus rectal misoprostol for third stage management after second-trimester abortion
IRCT2015020715795N2Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of oxytocin and misoprostol in stillbirth (2 arms), sponsored by Ardabil University of Medical Sciences. Started Aug 2014; status: completed.
02
Drugs
oxytocinmisoprostol
03
Conditions
stillbirth
Beyond the preview
Go deeper on IRCT2015020715795N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015020715795N2.